Skip to content
FY'25FY'24FY'23FY'22
Profitability
Operating margin33.3%+6.8pp26.5%+249pp-222%-283pp61%+4.8pp
Net margin8.1%+7.9pp0.3%+227pp-226.4%-269pp42.6%-85.1pp
Efficiency
Asset turnover0.8×-0.1×0.9×+0.3×0.6×+0.2×0.4×-0.1×
Liquidity
Current ratio1.1×-3.6×4.7×+3.8×0.8×-29.7×30.6×+26.0×
Leverage
Net debt / EBITDA-0×+0.7×-0.8×-2.5×-0.5×
Per Share
Book value per share-$1.61+14.7%-$1.88+15.5%-$2.23-164%$3.50-5.0%
Valuation
Market capitalization$632.12M+457%$708.93M-60.3%$1.78B-6.1%$1.9B-11.6%
Price / earnings6.2×805.6×10.9×+6.8×
Price / sales1.8×+1.4×-2.0×-0.6×4.6×-0.6×
EV / EBITDA3.1×+2.7×6.7×-2.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Ironwood Pharmaceuticals's profit margins?
Ironwood Pharmaceuticals (IRWD) runs a 99.2% gross margin and a 55.4% operating margin, with a 28.3% net margin.
Where do Ironwood Pharmaceuticals's ratios come from?
Every ratio is computed from Ironwood Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.